Latest filing published 05 May 2009 for HAEMONETICS CORP, €14k.
Insider track record
No signal scores available.
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +9.2%Entry US$25.52 · Close at T+365 US$27.87
- -1.5%Entry US$28.30 · Close at T+365 US$27.89
- +8.5%Entry US$24.80 · Close at T+365 US$26.91
- +26.7%Entry US$22.55 · Close at T+365 US$28.57
- -3.2%Entry US$25.78 · Close at T+365 US$24.97
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert B. Ebbeling: trading record in brief
This profile gathers the share dealings of Robert B. Ebbeling in Haemonetics Corp. In total, 19 filings cover trades dated from 1 May 2006 to 1 May 2009.
Both buying and selling appear: 6 purchases worth €59k, against 6 sales worth €2.4M. Sales outweigh purchases by €2.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant and 6 option exercises. In 2009 alone, the filings show 1 purchase and no sales.
Half of the purchases are above €11k and half below. After 5 purchases with a full 90-day history, the hit rate stands at 60% and the median 90-day move at +1.0%. This is a record of the past, not a forecast.
The latest filing, published on 5 May 2009, reports an open-market purchase of €14k in Haemonetics Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert B. Ebbeling
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 424 shares@ US$43.89Common StockSEC:0000313143-09-000025:0Canonical exit: 30 Jul 2009 (T+90)
- 18,904 shares@ US$15.88Common StockSEC:0000313143-08-000065:0
- 18,904 shares@ US$65.00Common StockSEC:0000313143-08-000065:1
- 2,748 shares@ US$22.91Common StockSEC:0000313143-08-000065:2
- 2,748 shares@ US$65.00Common StockSEC:0000313143-08-000065:3
- 10,500 shares@ US$15.41Common StockSEC:0000313143-08-000064:0
- 10,500 shares@ US$65.00Common StockSEC:0000313143-08-000064:1
- 11,146 shares@ US$22.91Common StockSEC:0000313143-08-000064:2
- 11,146 shares@ US$65.00Common StockSEC:0000313143-08-000064:3
- 144 shares@ US$40.66Common StockSEC:0000313143-07-000060:0Canonical exit: 30 Jan 2008 (T+90)
- 1,179 shares@ US$0.01Common StockSEC:0000313143-07-000051:0
- 397 shares@ US$38.63Common StockSEC:0000313143-07-000020:0Canonical exit: 30 Jul 2007 (T+90)
- 2,300 shares@ US$17.00Common StockSEC:0000313143-07-000013:0
- 2,300 shares@ US$47.03Common StockSEC:0000313143-07-000013:1
- 10,000 shares@ US$17.00Common StockSEC:0000313143-07-000013:2
- 10,000 shares@ US$47.01Common StockSEC:0000313143-07-000013:3
- 184 shares@ US$38.76Common StockSEC:0000313143-06-000122:0Canonical exit: 30 Jan 2007 (T+90)
- 307 shares@ US$41.52Common StockSEC:0000313143-06-000026:0Canonical exit: 30 Jul 2006 (T+90)
18 of 18 declarations
